Approval · Notice of Compliance 20149 · 2017
CIPRO: Notice of Compliance 20149
Issued December 11, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20149
- Date
- December 11, 2017
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the product monograph with revised indications
Products in this notice
Medicinal ingredients
- CIPROFLOXACIN 500 MG per TAB
- CIPROFLOXACIN 250 MG per TAB
- CIPROFLOXACIN 750 MG per TAB
- CIPROFLOXACIN 10 G per 100ML